BRL 14151,
BRL-14151,
BRL14151,
Clavulanate,
Clavulanate Potassium,
Clavulanate, Potassium,
Clavulanate, Sodium,
Clavulanic Acid,
Clavulanic Acid, Monopotassium Salt,
Clavulanic Acid, Monosodium Salt,
MM 14151,
MM-14151,
MM14151,
Potassium Clavulanate,
Potassium, Clavulanate,
Sodium Clavulanate,
Potassium clavulanate,
61177-45-5,
CLAVULANATE POTASSIUM,
Amonate,
BRL 14151K,
UNII-Q42OMW3AT8,
EINECS 262-640-9,
Q42OMW3AT8,
CHEBI:85264,
potassium (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate,
Potassium (Z)-(2R,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylate,
Potassium clavulanate with microcrystalline cellulose,
4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt, (2R-(2alpha,3Z,5alpha))-,
Potassium (2R-(2alpha,3Z,5alpha))-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylate,
Clavulansaeure kaliumsalz,
Clavulanic Acid Potassium Salt,
Clavulanate potassium [USAN:JAN],
DRG-0225,
Clavulanate potassium [USAN:USP:JAN],
(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate,
CHEMBL1003,
C8H8NO5.K,
SCHEMBL203411,
BIC581,
CLAVULANIC ACID POTASSIUM,
DTXSID60210067,
ABVRVIZBZKUTMK-JSYANWSFSA-M,
BRL-14151K,
HMS3715B13,
Clavulanate potassium (JP17/USP),
BCP13548,
Clavulanic Acid, Monopotassium Salt,
MFCD01710901,
AKOS015961326,
CCG-221126,
MM 1415,
AC-13551,
AK109416,
AN-39326,
BP-30181,
LS-98546,
SC-18401,
AX8148761,
TL8003882,
ST24048996,
C-6660,
D02370,
A833076,
Clavulanate Potassium+Microcrystalline cellulose(1:1),
Potassium clavulanate (40%) : silicon dioxide mixture,
Potassium clavulanate (50%) : microcrystalline cellulose,
Clavulanate potassium salt, Antibiotic for Culture Media Use Only,
(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2beta-carboxylic acid potassium salt,
potassium (2R,3Z,5R)-3-(2-oxidanylethylidene)-7-oxidanylidene-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate,
potassium (2R,5R,Z)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate,
potassium;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate,
Augmentin,
Timentin,
Mixture Name,
Clavulanate+Amoxicillin,
D05BCF,
C8H8KNO5,
C8H9NO5.K,
C8-H8-N-O5.K,
CID6434607,
CS-O-06232,
CVA,
4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monopotassium salt, (2R,3Z,5R)-,
Potassium [2R-(2alpha,3Z,5alpha)]-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate,